RSV Distribution Preference

Manitoba Public Health is asking for physician feedback by July 20 on which nirsevimab distribution approach you prefer.

Option 1 – Rotavirus Proxy Model (Data-Driven Approach): The last two years of rotavirus shipping data would be used to calculate an initial allocation that each site would receive. That pre-determined amount of supply would be sent in September, with the opportunity to order and receive additional doses within about a week of re-ordering.

Option 2 – Appointment-Based Model (Provider-Driven Allocation): The initial allocation would be calculated based on the number of scheduled appointments for eligible infants in October and November reported to Manitoba Health by each location prior to the season and would also include the opportunity to re-order additional doses as needed after initial distribution in September.
1.Do you prefer option 1 or option 2 when it comes to allocating RSV (nirsevimab) to your clinic?
2.Why do you prefer that option (optional)
3.What is your specialty?
4.What is your primary health region:
Privacy & Cookie Notice